Stockreport

GH Research Reports Full Year 2025 Financial Results and Provides Business Update

GH Research PLC - Ordinary Shares  (GHRS) 
PDF Completed Phase 2b trial of GH001 in TRD and presented the full dataset at the 2025 ASCP and ECNP congressesGH001 cleared by FDA for U.S. clinical investigation, enablin [Read more]